GS441 plus+ GS-441524 Injection

GS441 plus+ is the named injectable entry with a listed 20 mg/mL concentration and 6 mL vial. The ingredient GS-441524 has been studied in feline infectious peritonitis, but a specific marketed vial must be distinguished from ingredient-level research.

Research and product identity have different roles

Feline studies concern defined GS-441524 formulations and clinical protocols. They can provide ingredient background; they do not establish the manufacturer, concentration accuracy or clinical quality of a different labelled vial.

The six-millilitre presentation

The listed concentration is 20 mg/mL and the vial volume is 6 mL. This is a separate presentation from the 8 mL GS-441524 injection/tablet range entry. Keep concentration and volume together when identifying the required item.

Prescribing and supply context

The FDA reference on certain compounded GS-441524 products describes specific conditions and veterinary prescribing. A compound’s ingredient name does not mean every commercial brand or vial has the same status. The exact product label and formulation matter to a veterinary enquiry.

Handling follows the actual formulation

Keep the complete vial label with the clinical instructions and identify the intended animal. Research protocols or instructions for another oral or injectable product should not be used to prepare or administer an unspecified vial.